About 100 reports

  • STAGE DEFINITIONS FOR COLORECTAL CANCER
  • TREATMENT DURATION IN COLORECTAL CANCER

NY-ESO-## IS A CANCER ANTIGEN EXPRESSED IN A VARIETY OF CANCERS, INCLUDING COLORECTAL, RENAL AND ESOPHAGEAL.

  • Colorectal Cancer
  • Eli Lilly & Co.
  • Merck & Co., Inc.
  • Roche Group
  • Taiho Pharmaceutical Co., Ltd.
  • Aging Population to Increase Disease Prevalence
  • CRC THERAPEUTICS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, PRE-REGISTRATION, 2018

Annals of Colorectal Research; ##(##): ##-## Roche (2017).

  • Chemotherapy
  • Colorectal Cancer
  • Therapy
  • Market Size
  • Merck & Co., Inc.
  • 3.1 BIBLIOGRAPHY
  • MM, Five-Year Diagnosed Prevalent Cases of CRC (N), Both Sexes, Ages ≥18 Years,

BMC Cancer; ##(##): ##.

  • Colorectal Cancer
  • China
  • United States
  • Forecast
  • Cancer Epidemiology Group
  • Colorectal Cancer Development Pipeline, by Phase
  • Top Targets for Drug Development Against Colorectal Cancer

Colorectal Cancer: Competitive Landscape to 2026 Report Code: GDHC##CL Published: April 2018 Healthcare TABLE OF CONTENTS ##.

  • Colorectal Cancer
  • China
  • United States
  • Array BioPharma Inc.
  • Eli Lilly & Co.

Global Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Colorectal Cancer
  • France
  • United States
  • World
  • Forecast

Colorectal Cancer: Update Bulletin ### This edition presents the views and insights from three world leading key opinion leaders (KOLs) from North America and Europe on a variety of recent events in the colorectal cancer (CRC) market, including; Symphogen

  • Colorectal Cancer
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • Europe

Colorectal Cancer: Update Bulletin ### [March 2018] Gain new key opinion leader (KOL) insights on the latest events happening in the CRC treatment landscape Topics covered include expert opinions on; the potential of MabVax Therapeutics’ human antibody-based radioimmunotherapy produ

  • Cancer Immunotherapy
  • Colorectal Cancer
  • Oncology
  • Therapy

Products in the pipeline are striving to meet some of the unmet needs of the colorectal cancer (CRC) market.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • United States
  • Forecast
  • 5.2 References
  • Introduction

Etiology of colorectal cancer.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • Therapy
  • Roche Group

Colorectal Cancer Forecast and Market Analysis to 2036 FORECAST: COLORECTAL CANCER IN THE US, JAPAN, AND ##EU (Published on ## December 2017) EXECUTIVE SUMMARY RECENT FORECAST UPDATES MARKET DYNAMICS FORECAST AND FUTURE TRENDS MARKET DEFINITION AND METHODOLOGY PRIM

  • Cancer
  • Colorectal Cancer
  • European Union
  • Japan
  • United States

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Colorectal Cancer
  • France
  • United States
  • Market Shares
  • Market Size
  • TREATMENT OF COLORECTAL CANCER PATIENTS
  • Duke's Staging Of Colorectal Cancer

Quality of medical care in colorectal cancer in Germany Onkologie. 2009; ##((##- ##)):##-##. ##.

  • Colorectal Cancer
  • Italy
  • North America
  • South America
  • Southern Europe

Europe Colorectal Cancer Epidemiology and Patient Flow Analysis - 2017 ##.

  • Colorectal Cancer
  • Europe
  • France
  • Germany
  • Forecast

Colorectal cancer

4385 5000 3900
  • Colorectal cancer Disease Coverage | Pipeline: Colorectal Cancer
  • Colorectal cancer Disease Coverage | Pipeline: Colorectal Cancer

TS-## FORECAST, 2015-## FIGURE ##: TS-## SALES FOR COLORECTAL CANCER IN JAPAN ($M), 2015-## TABLE ##: TS-## SALES FOR COLORECTAL CANCER IN JAPAN ($M), 2015-## The table below shows Datamonitor Healthcare' s forecast of the total number

  • Colorectal Cancer
  • European Union
  • Japan
  • North America
  • United States
  • Global Colorectal Cancer Drugs Market
  • Global Colorectal Cancer Drugs Market

The magnitude of the impact has been categorized as described below: Low Moderate - Medium-level impact on the market High - Negligible or no impact on the market landscape - Very high impact, with radical influence on the growth of the market ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck Serono S.A.
  • Percentage of New Cases of Colorectal Cancer in U.S, By Age Group 2018
  • Percentage of Deaths of Colorectal Cancer in U.S, By Age Group, 2018

The lifetime risk of developing colorectal cancer is ## in ##.

  • Colorectal Cancer
  • North America
  • World
  • Market Size
  • Boston Scientific Corporation
  • COLORECTAL CANCER BIOSIMILAR LANDSCAPE
  • HER2+ Breast Cancer

Colorectal Cancer: Competitive Landscape to 2026, April 2018, GDHC##CL GlobalData (2017).

  • Colorectal Cancer
  • Biocon Limited
  • Mylan Inc.
  • Pfizer Inc.
  • Sandoz Inc.
  • Local colorectal cancer symptoms
  • Systemic colorectal cancer symptoms

Biologics are one of the treatment choices for colorectal cancer.

  • Colorectal Cancer
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Sanofi S.A.

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Colorectal Cancer
  • France
  • Germany
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Japan
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • United States
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • United Kingdom
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Italy
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Germany
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • France
  • Market Shares
  • Market Size

Colorectal Cancer Phase ## Clinical Trials, 2016 ##.

  • Cancer
  • Colorectal Cancer
  • Spain
  • Market Shares
  • Market Size
  • 1.1 Colorectal Cancer
  • GLOBAL COLORECTAL CANCER INCIDENCES FORECAST (2017-2022)

Poor quality of the tests has been proposed as one of the possible factors explaining the lack of a protective effect of colonoscopy for proximal colorectal cancer.

  • Colorectal Cancer
  • United States
  • Forecast
  • Epigenomics AG
  • Exact Sciences Corp.

COLORECTAL CANCER DRUGS INDUSTRY AND MARKET: THERAPIES, R& D AND FORECASTS 2015-2025 Table of Contents ##.

  • Cancer
  • Colorectal Cancer
  • Pathology
  • World
  • Market Size
  • 11.1 Factors Impacting Market Growth
  • COLONOSCOPY DEVICES MARKET IN AMERICAS

In the US alone, colorectal cancer is the second leading cause of cancer deaths in 2015.

  • Colorectal Cancer
  • Boston Scientific Corporation
  • FUJIFILM Holdings Corporation
  • Hoya Corporation
  • Olympus Corporation

Drug analysis: Vectibix Product Profiles Vectibix : Colorectal cancer (CRC) LIST OF FIGURES Figure ##: Vectibix for colorectal cancer – SWOT analysis Figure ##: Datamonitor Healthcare’s drug assessment summary of Vectibix for colorectal

  • Colorectal Cancer
  • Monoclonal Antibody
  • European Union
  • Japan
  • United States